International Flavors & Fragrances Reports Decline in Q3 and Nine-Month Sales for 2025

International Flavors & Fragrances Inc. (IFF) reported a decline in financial performance for the third quarter and first nine months of 2025, as detailed in its latest 10-Q filing. For the three months ended September 30, 2025, the company recorded net sales of $2.694 billion, an 8% decrease from $2.925 billion in the same period of 2024. The nine-month figures also reflected a 5% decline, with sales totaling $8.301 billion compared to $8.713 billion in 2024. The decrease in revenue was attributed to a change in business portfolio mix due to divestitures, particularly the sale of the Pharma Solutions and Nitrocellulose businesses, which impacted sales by approximately $506 million.

Gross profit for the third quarter fell to $983 million, down 7% from $1.052 billion in the prior year, while gross margin improved slightly to 36.5% from 36.0%. The decline in gross profit was primarily driven by the divestiture impacts, which accounted for a loss of approximately $103 million, although this was partially offset by favorable pricing and productivity gains. The company reported a net loss attributable to IFF shareholders of $40 million, or $0.16 per diluted share, compared to a profit of $58 million, or $0.23 per diluted share, in the previous year.

Strategically, IFF has undergone significant organizational changes, including a reorganization of its internal structure effective January 1, 2025, which resulted in the separation of its Nourish segment into two new reportable segments: Taste and Food Ingredients. This restructuring aims to enhance operational efficiency and align resources more effectively. The company also announced a new share repurchase program valued at $500 million, which commenced in the fourth quarter of 2025.

Operationally, IFF's employee headcount remained stable, with no significant changes reported. The company continues to focus on enhancing its product offerings and expanding its market presence, particularly in the Taste and Scent segments, which reported sales increases of 2% and 6%, respectively, in the third quarter. However, the Pharma Solutions segment saw a complete cessation of sales following its divestiture, which significantly impacted overall revenue figures.

Looking ahead, IFF anticipates that the divestitures will allow for a more focused approach to its core business segments, potentially leading to improved profitability in the long term. The company expects to leverage its cash flow from operations and proceeds from divestitures to support ongoing investments and maintain its dividend policy. Despite the challenges faced in 2025, IFF remains committed to its strategic transformation and aims to enhance shareholder value through disciplined capital allocation and operational improvements.